Workflow
中银晨会聚焦-20250624

Core Insights - The report highlights the rapid growth of the company, with 2024 revenue reaching 21.61 billion yuan, a year-on-year increase of 42.95%, and net profit attributable to shareholders at 5.87 billion yuan, up 117.01% [2][5][6] - The company plans to distribute a cash dividend of 5.00 yuan per 10 shares to all shareholders [2][5] - The nutritional products segment saw significant growth, with revenue of 15.06 billion yuan in 2024, a 52.58% increase year-on-year, driven by the release of new production capacity and recovery in the downstream aquaculture industry [7][8] Financial Performance - In Q4 2024, the company achieved revenue of 5.83 billion yuan, a 41.99% increase year-on-year, but a slight decrease of 1.84% quarter-on-quarter [2][5] - For Q1 2025, revenue was 5.44 billion yuan, a 20.91% increase year-on-year, but a 6.66% decrease quarter-on-quarter [2][5] - The gross margin for 2024 was 41.78%, up 8.80 percentage points year-on-year, while the net margin was 27.29%, an increase of 9.26 percentage points [6] Product and Market Insights - The average price of key products in the nutritional segment increased significantly in 2024, with VA averaging 133.48 yuan/kg (up 58.12%), VE at 100.84 yuan/kg (up 42.82%), and methionine at 20.90 yuan/kg (up 19.25%) [7] - The company has successfully released 300,000 tons/year of methionine production capacity and is progressing on a joint venture project with Sinopec for an 180,000 tons/year liquid methionine project [7][8] Project Development - The company is actively advancing new projects in flavors and fragrances, new materials, and active pharmaceutical ingredients, with the flavors and fragrances segment generating revenue of 3.92 billion yuan in 2024, a 19.62% increase [8] - The new materials segment achieved revenue of 1.68 billion yuan, a 39.51% increase, with ongoing development in PPS applications and nylon new materials [8]